Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hispolon is a phenolic compound derived from Phellinus species mushrooms that demonstrates potent anti-cancer activity through apoptosis induction and cell cycle arrest. This bioactive compound also exhibits significant anti-inflammatory and antioxidant properties by modulating cytokine production and neutralizing reactive oxygen species.
Reported Benefits (Provisional)
Origin & History
Hispolon is a bioactive compound extracted from the Phellinus mushroom, which grows on trees in tropical and subtropical regions.
Research Narrative (Provisional)
Studies on Hispolon suggest it has anti-cancer and anti-inflammatory effects, with ongoing research into its mechanisms of action.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"protein": "2-3 g per 100 g", "fiber": "1-2 g per 100 g"}, "micronutrients": {"vitamins": {"Vitamin D": "0.2-0.5 \u00b5g per 100 g"}, "minerals": {"Potassium": "200-300 mg per 100 g", "Calcium": "5-10 mg per 100 g"}}, "bioactive_compounds": {"Hispolon": "0.1-0.5 mg per 100 g", "Polysaccharides": "5-10 g per 100 g"}, "bioavailability_notes": "The bioavailability of hispolon and polysaccharides may vary based on preparation methods. Cooking can enhance the bioavailability of certain compounds, while excessive heat may degrade some nutrients."}
Reported Mechanism (Provisional)
Hispolon induces cancer cell apoptosis through p53 pathway activation and mitochondrial membrane potential disruption, leading to caspase cascade activation. The compound inhibits pro-inflammatory cytokines including TNF-α and IL-6 via NF-κB pathway suppression. Its antioxidant effects stem from direct free radical scavenging and upregulation of endogenous antioxidant enzymes like catalase and superoxide dismutase.
Clinical Narrative (Provisional)
Research on hispolon consists primarily of in vitro and animal studies, with limited human clinical trials. Laboratory studies demonstrate IC50 values ranging from 10-50 μM against various cancer cell lines including hepatoma and breast cancer cells. Animal studies using doses of 25-100 mg/kg body weight show significant tumor growth inhibition and reduced inflammatory markers. Human clinical evidence remains preliminary, with most benefits extrapolated from preclinical research requiring validation in larger controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.